| Literature DB >> 35949561 |
Aliyu T Jibril1, Parivash Ghorbaninejad1, Fatemeh Sheikhhossein1, Sakineh Shab-Bidar1.
Abstract
Metabolic syndrome (MetS) is a multifactorial disease with its exact causes not completely clear. Micronutrients such as vitamin A, vitamin D, zinc, and magnesium have been associated with MetS components. Our objective was to investigate the association of nutrient adequacy (NA) with MetS components. The present cross-sectional study consisted of 850 adults between 18-59 years from Tehran, Iran. Dietary intake, socio-demographic data, medical history, and anthropometric indices were collected by trained personnel. NA was calculated as the mean intake ratio to the recommended amount of 16 micronutrients. MetS were defined by the consensus of National Cholesterol Education Program-Adult Treatment Panel III criteria. The association between NA and MetS was examined using linear regression analyses after controlling potential confounders. More participants in the highest quartile were obese in terms of general obesity (p = 0004) and abdominal obesity (p = 0.003) compared with subjects in the least quartile. A significant positive correlation was found between waist circumference (WC) and NA even after controlling for all potential confounders (p < 0.001). NA was positively associated with WC among adults living in Tehran.Entities:
Keywords: Metabolic syndrome; Micronutrient; Nutrient adequacy; Obesity; Waist circumference
Year: 2022 PMID: 35949561 PMCID: PMC9348912 DOI: 10.7762/cnr.2022.11.3.204
Source DB: PubMed Journal: Clin Nutr Res ISSN: 2287-3732
General characteristics of participants across quartiles of energy-adjusted nutrient adequacy
| Variables | Quartiles of nutrient adequacy | ||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | p value* | |
| Samples | 212 (24.90) | 214 (25.20) | 212 (24.90) | 212 (24.90) | |
| Q ranges | ≤ 0.6861 | 0.6862–0.7792 | 0.7793–0.8525 | ≥ 0.8526 | |
| Age (yr) | 45.74 ± 10.54 | 45.19 ± 10.13 | 44.36 ± 11.15 | 43.67 ± 11.11 | 0.20 |
| BMI (kg/m2) | 26.81 ± 4.30 | 28.07 ± 4.54 | 28.27 ± 7.25 | 28.30 ± 5.58 | 0.01 |
| WC (cm) | 90.18 ± 13.17 | 93.08 ± 12.12 | 92.53 ± 11.69 | 92.49 ± 12.59 | 0.07 |
| FBG (mg/dL) | 107.73 ± 57.23 | 109.37 ± 42.63 | 110.04 ± 35.17 | 106.53 ± 31.50 | 0.83 |
| TG (mg/dL) | 149.16 ± 87.46 | 139.43 ± 72.32 | 147.54 ± 77.18 | 145.63 ± 80.18 | 0.60 |
| HDL-c (mg/dL) | 49.74 ± 9.88 | 50.76 ± 10.43 | 49.28 ± 10.39 | 49.76 ± 10.12 | 0.49 |
| SBP (mmHg) | 119.03 ± 26.19 | 120.49 ± 22.60 | 119.40 ± 19.89 | 119.92 ± 20.22 | 0.91 |
| DBP (mmHg) | 78.80 ± 15.09 | 78.47 ± 15.13 | 78.17 ± 12.94 | 78.00 ± 12.07 | 0.93 |
| Gender (men) | 80 (30.10) | 74 (27.80) | 65 (24.40) | 47 (17.70) | 0.004 |
| Education (university graduate) | 62 (21.20) | 80 (27.40) | 75 (25.70) | 75 (25.70) | 0.30 |
| Occupation (employed) | 55 (25.00) | 57 (25.90) | 44 (20.00) | 64 (29.10) | 0.15 |
| Marital status (married) | 169 (24.60) | 172 (25.00) | 173 (25.10) | 174 (25.30) | 0.96 |
| Smoking status (current smoker) | 13 (29.50) | 11 (25.00) | 10 (22.70) | 10 (22.70) | 0.97 |
| Physically active (moderate) | 75 (24.20) | 78 (25.20) | 80 (25.80) | 77 (24.80) | 0.77 |
| General obesity† | 40 (16.70) | 62 (25.80) | 68 (28.30) | 70 (29.20) | 0.004 |
| Abdominal obesity‡ | 80 (19.30) | 114 (27.50) | 107 (25.80) | 113 (27.30) | 0.003 |
| Metabolic syndrome§ | 22 (21.40) | 31 (30.10) | 28 (27.20) | 22 (21.40) | 0.46 |
Data are presented as mean ± SD or number (%).
BMI, body mass index; WC, waist circumference; FBG, fasting blood glucose; TG, triglyceride; HDL-c, high-density lipoprotein-cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure.
*Calculated by χ2 and analysis of variance for qualitative and quantitative variables, respectively and p < 0.05 indicates a significant level; †General obesity is considered as BMI ≥ 30 kg/m2; ‡Abdominal obesity is considered as WC ≥ 88 cm for women and ≥ 102 cm for men; §Hypertriglyceridemia, Hypertension, Hyperglycemia, Low-High Density Lipoprotein cholesterol, Enlarged waist circumference.
Dietary intakes of participants across quartiles of energy-adjusted nutrient adequacy
| Variables | Quartiles of nutrient adequacy | |||||
|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | p value* | p-trend† | |
| Range | ≤ 0.6861 | 0.6862–0.7792 | 0.7793–0.8525 | ≥ 0.8526 | ||
| MAR | 0.57 ± 0.11 | 0.73 ± 0.02 | 0.81 ± 0.02 | 0.90 ± 0.04 | < 0.001 | < 0.001 |
| Total energy (kcal/d) | 1,931.87 ± 922.13 | 2,472.18 ± 3,347.57 | 2,501.61 ± 880.38 | 3,369.22 ± 1,410.96 | < 0.001 | < 0.001 |
| Total fat (g/d) | 62.33 ± 39.99 | 70.98 ± 31.32 | 77.19 ± 30.72 | 118.87 ± 71.81 | < 0.001 | < 0.001 |
| MUFA (%) | 22.56 ± 47.27 | 21.81 ± 12.03 | 23.28 ± 10.63 | 35.69 ± 23.72 | < 0.001 | < 0.001 |
| PUFA (%) | 12.70 ± 7.89 | 15.85 ± 9.42 | 15.38 ± 7.63 | 24.61 ± 19.12 | < 0.001 | < 0.001 |
| Carbohydrate (g/d) | 290.54 ± 150.42 | 396.28 ± 858.36 | 370.35 ± 143.67 | 481.82 ± 220.66 | < 0.001 | < 0.001 |
| Protein (g/d) | 64.78 ± 34.26 | 79.12 ± 57.32 | 86.65 ± 30.27 | 115.36 ± 50.09 | < 0.001 | < 0.001 |
| Dietary fiber (g/d) | 19.79 ± 124.89 | 23.75 ± 123.78 | 19.49 ± 7.37 | 30.09 ± 14.06 | 0.57 | 0.62 |
| Vitamin A (µg/d) | 997.73 ± 4,213.41 | 1,288.31 ± 4,181.84 | 1,511.81 ± 981.36 | 2,921.29 ± 2,270.46 | < 0.001 | < 0.001 |
| Vitamin B1 (mg/d) | 0.97 ± 0.65 | 1.53 ± 0.70 | 1.78 ± 0.84 | 2.38 ± 1.15 | < 0.001 | < 0.001 |
| Vitamin B2 (mg/d) | 0.42 ± 0.47 | 1.01 ± 0.42 | 1.48 ± 0.83 | 2.57 ± 1.46 | < 0.001 | < 0.001 |
| Vitamin B3 (mg/d) | 19.28 ± 78.00 | 24.54 ± 77.13 | 22.97 ± 8.87 | 31.48 ± 14.47 | 0.14 | 0.10 |
| Vitamin B6 (mg/d) | 0.36 ± 0.44 | 0.80 ± 0.52 | 1.40 ± 0.78 | 2.41 ± 1.32 | < 0.001 | < 0.001 |
| Vitamin B9 (µg/d) | 199.26 ± 283.28 | 278.66 ± 279.23 | 345.90 ± 122.95 | 560.85 ± 251.68 | < 0.001 | < 0.001 |
| Vitamin B12 (µg/d) | 1.60 ± 0.98 | 2.96 ± 1.81 | 4.33 ± 5.46 | 6.63 ± 6.39 | < 0.001 | < 0.001 |
| Vitamin C (mg/d) | 126.46 ± 523.83 | 164.21 ± 519.30 | 180.63 ± 115.38 | 318.07 ± 222.49 | < 0.001 | < 0.001 |
| Vitamin D (µg/d) | 0.60 ± 0.89 | 1.27 ± 1.30 | 1.82 ± 1.73 | 3.95 ± 3.74 | < 0.001 | < 0.001 |
| Vitamin E (mg/d) | 2.54 ± 2.47 | 3.61 ± 2.91 | 4.80 ± 4.36 | 10.12 ± 10.28 | < 0.001 | < 0.001 |
| Calcium (mg/d) | 1,224.28 ± 1,374.68 | 1,538.25 ± 1,435.53 | 1,679.10 ± 1,448.95 | 1,905.17 ± 1,339.94 | < 0.001 | < 0.001 |
| Phosphorus (mg/d) | 673.70 ± 378.85 | 894.32 ± 1,067.59 | 1,038.66 ± 530.64 | 1,759.40 ± 964.00 | < 0.001 | < 0.001 |
| Magnesium (mg/d) | 217.06 ± 131.93 | 289.51 ± 553.11 | 274.77 ± 113.43 | 418.67 ± 203.13 | < 0.001 | < 0.001 |
| Iron (mg/d) | 54.63 ± 93.21 | 70.71 ± 149.95 | 66.33 ± 102.80 | 57.44 ± 98.46 | 0.42 | 0.99 |
| Potassium (mg/d) | 2,622.55 ± 1,419.45 | 4,211.42 ± 15,243.05 | 3,473.37 ± 1,150.68 | 5,567.81 ± 2,938.86 | 0.001 | 0.001 |
| Zinc (mg/d) | 7.11 ± 10.43 | 8.23 ± 9.10 | 9.28 ± 8.81 | 12.79 ± 6.64 | < 0.001 | < 0.001 |
Data are presented as mean ± SD.
MAR, mean adequacy ratio; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid.
*Calculated by analysis of variance and p < 0.05 indicates significant level; †Based on Post Hoc Test and p < 0.05 indicates a significant level.
Association of energy-adjusted nutrient adequacy with metabolic syndrome components
| Variables | Nutrient adequacy | ||||
|---|---|---|---|---|---|
| β (SE) | 95% CI | R2 | p value* | ||
| TG (mg/dL) | |||||
| Crude | 0.02 (19.99) | −27.47, 51.02 | < 0.001 | 0.55 | |
| Model 1† | 0.02 (20.07) | −27.13, 51.65 | 0.003 | 0.54 | |
| Model 2‡ | 0.02 (20.22) | −24.32, 55.08 | 0.01 | 0.44 | |
| SBP (mmHg) | |||||
| Crude | 0.03 (5.62) | −5.42, 16.66 | 0.001 | 0.31 | |
| Model 1† | 0.05 (5.22) | −2.05, 18.44 | 0.14 | 0.11 | |
| Model 2‡ | 0.05 (5.19) | −2.05, 18.33 | 0.17 | 0.11 | |
| DBP (mmHg) | |||||
| Crude | −0.01 (3.49) | −8.45, 5.24 | < 0.001 | 0.64 | |
| Model 1† | −0.006 (3.42) | −7.36, 6.08 | 0.04 | 0.85 | |
| Model 2‡ | −0.02 (3.34) | −9.38, 3.73 | 0.11 | 0.39 | |
| FBG (mg/dL) | |||||
| Crude | −0.002 (10.76) | −21.82, 20.42 | < 0.001 | 0.94 | |
| Model 1† | 0.001 (10.80) | −20.79, 21.61 | 0.002 | 0.97 | |
| Model 2‡ | −0.001 (10.85) | −21.47, 21.13 | 0.01 | 0.98 | |
| HDL-c (mg/dL) | |||||
| Crude | −0.04 (2.56) | −8.03, 2.05 | 0.002 | 0.24 | |
| Model 1† | −0.04 (2.57) | −8.18, 1.92 | 0.006 | 0.22 | |
| Model 2‡ | −0.04 (2.58) | −8.66, 1.49 | 0.02 | 0.16 | |
| WC (cm) | |||||
| Crude | 0.10 (3.11) | 3.78, 16.00 | 0.01 | 0.002 | |
| Model 1† | 0.13 (2.79) | 6.93, 17.91 | 0.21 | < 0.001 | |
| Model 2‡ | 0.13 (2.76) | 6.84, 17.70 | 0.23 | < 0.001 | |
β, standardized coefficients; SE, standard error; CI, confidence interval; R2, R square; TG, triglyceride; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL-c, high-density lipoprotein-cholesterol; WC, waist circumference.
*These p values are reported based on the linear regression test and are considered significant at < 0.05; †Model 1: adjusted for age + sex; ‡Model 2: Model 1 + total physical activity + smoking habits + educational level + BMI + marital status + occupation.
Odds ratio and 95% confidence interval for metabolic syndrome and its components across quartiles of nutrient adequacy
| Variables | Quartiles of nutrient adequacy | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q1 (n = 212) | Q2 (n = 214) | Q3 (n = 212) | Q4 (n = 212) | ||||||
| Reference | p value* | OR (95% CI) | p value* | OR (95% CI) | p value* | OR (95% CI) | p value* | ||
| Metabolic syndrome | |||||||||
| Crude | 1 | 0.46 | 1.46 (0.81–2.62) | 0.20 | 1.31 (0.72–2.38) | 0.36 | 1.00 (0.53–1.86) | 1.00 | |
| Model 1† | 1 | 0.45 | 1.46 (0.81–2.63) | 0.20 | 1.32 (0.72–2.40) | 0.35 | 0.99 (0.52–1.86) | 0.98 | |
| Model 2‡ | 1 | 0.44 | 1.45 (0.80–2.61) | 0.21 | 1.30 (0.71–2.38) | 0.38 | 0.96 (0.51–1.82) | 0.91 | |
| Hypertriglyceridemia | |||||||||
| Crude | 1 | 0.40 | 0.83 (0.56–1.24) | 0.37 | 1.17 (0.79–1.72) | 0.42 | 0.94 (0.63–1.39) | 0.76 | |
| Model 1† | 1 | 0.41 | 0.83 (0.56–1.24) | 0.37 | 1.16 (0.78–1.71) | 0.44 | 0.93 (0.63–1.39) | 0.74 | |
| Model 2‡ | 1 | 0.40 | 0.85 (0.57–1.27) | 0.44 | 1.20 (0.80–1.78) | 0.36 | 0.97 (0.65–1.45) | 0.89 | |
| Hypertension | |||||||||
| Crude | 1 | 0.93 | 0.95 (0.57–1.59) | 0.86 | 0.86 (0.51–1.46) | 0.59 | 0.86 (0.51–1.46) | 0.59 | |
| Model 1† | 1 | 0.87 | 0.94 (0.56–1.57) | 0.83 | 0.84 (0.50–1.42) | 0.52 | 0.83 (0.49–1.40) | 0.48 | |
| Model 2‡ | 1 | 0.86 | 0.95 (0.56–1.60) | 0.85 | 0.85 (0.50–1.46) | 0.56 | 0.81 (0.47–1.39) | 0.44 | |
| Hyperglycemia | |||||||||
| Crude | 1 | 0.29 | 1.14 (0.62–2.09) | 0.66 | 1.53 (0.86–2.74) | 0.14 | 0.90 (0.47–1.70) | 0.74 | |
| Model 1† | 1 | 0.29 | 1.14 (0.62–2.11) | 0.65 | 1.55 (0.86–2.78) | 0.13 | 0.92 (0.48–1.75) | 0.80 | |
| Model 2‡ | 1 | 0.24 | 1.16 (0.62–2.15) | 0.62 | 1.60 (0.88–2.90) | 0.11 | 0.91 (0.47–1.76) | 0.79 | |
| Low HDL-c | |||||||||
| Crude | 1 | 0.98 | 1.02 (0.59–1.76) | 0.92 | 0.96 (0.55–1.66) | 0.88 | 0.92 (0.53–1.60) | 0.77 | |
| Model 1† | 1 | 0.99 | 1.03 (0.60–1.77) | 0.90 | 0.97 (0.56–1.68) | 0.92 | 0.95 (0.54–1.67) | 0.86 | |
| Model 2‡ | 1 | 0.98 | 1.11 (0.63–1.93) | 0.70 | 1.02 (0.58–1.80) | 0.92 | 1.02 (0.57–1.81) | 0.93 | |
| Enlarged WC | |||||||||
| Crude | 1 | 0.003 | 1.88 (1.27–2.76) | 0.001 | 1.68 (1.14–2.47) | 0.008 | 1.88 (1.27–2.77) | 0.001 | |
| Model 1† | 1 | 0.002 | 2.15 (1.40–3.29) | < 0.001 | 1.88 (1.23–2.89) | 0.004 | 1.98 (1.29–3.05) | 0.002 | |
| Model 2‡ | 1 | 0.001 | 2.25 (1.46–3.48) | < 0.001 | 1.92 (1.24–2.96) | 0.003 | 2.06 (1.33–3.19) | 0.001 | |
HDL-c, high-density lipoprotein-cholesterol; WC, waist circumference.
*These p values are reported based on the logistic regression test and are considered significant at < 0.05; †Model 1: adjusted for age + sex; ‡Model 2: Model 1 + total physical activity + smoking habits+ educational level + BMI + marital status + occupation.